Introduction

This page provides a comprehensive analysis of the known insider trading history of Michael F Demane. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Michael F Demane has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:NVRO / Nevro Corp. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Michael F Demane. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Michael F Demane as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-04-03 2025-04-03 4 NVRO NEVRO CORP
Common Stock
D - Sale to Issuer -58,266 0 -100.00
2025-04-03 2025-04-03 4 NVRO NEVRO CORP
Common Stock
D - Sale to Issuer -219,145 0 -100.00
2025-04-03 2025-04-03 4 NVRO NEVRO CORP
Common Stock
D - Sale to Issuer -164,344 0 -100.00
2025-04-03 2025-04-03 4 NVRO NEVRO CORP
Common Stock
D - Sale to Issuer -61,863 0 -100.00
2025-01-02 2024-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 7,056 61,863 12.87
2024-10-02 2024-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 4,695 54,807 9.37
2024-07-02 2024-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 3,117 50,112 6.63
2024-05-28 2024-05-23 4 NVRO NEVRO CORP
Common Stock
A - Award 19,169 46,995 68.89
2024-04-02 2024-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 1,817 33,205 5.79
2024-01-03 2023-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 1,219 31,388 4.04
2023-10-03 2023-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 1,365 30,169 4.74
2023-07-05 2023-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 1,032 28,804 3.72
2023-06-09 2023-06-07 4 NVRO NEVRO CORP
Common Stock
G - Gift -80,000 27,772 -74.23
2023-05-30 2023-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 6,754 107,772 6.69
2023-04-14 2023-04-12 4 NVRO NEVRO CORP
Common Stock
M - Exercise 80,291 101,018 387.37 18.00 1,445,238 1,818,324
2023-04-04 2023-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 726 20,727 3.63
2023-01-04 2022-12-30 4 NVRO NEVRO CORP
Common Stock
A - Award 662 20,001 3.42
2022-10-04 2022-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 563 19,339 3.00
2022-07-05 2022-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 598 44,900 1.35
2022-05-27 2022-05-26 4 NVRO NEVRO CORP
Common Stock
A - Award 4,155 44,302 10.35
2022-04-04 2022-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 362 40,147 0.91
2022-01-04 2021-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 323 44,433 0.73
2021-10-04 2021-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 225 231,660 0.10
2021-07-02 2021-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 158 231,435 0.07
2021-06-24 2021-06-22 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,445 231,277 -2.71 179.03 -1,153,837 41,405,128
2021-05-26 2021-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 1,167 237,722 0.49
2021-04-02 2021-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 188 236,555 0.08
2021-01-05 2020-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 160 236,367 0.07
2020-10-13 2020-10-12 4 NVRO NEVRO CORP
Common Stock
S - Sale X -200 236,207 -0.08 151.62 -30,324 35,813,705
2020-10-13 2020-10-12 4 NVRO NEVRO CORP
Common Stock
S - Sale X -703 236,407 -0.30 151.09 -106,219 35,719,537
2020-10-13 2020-10-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -20,529 237,110 -7.97 150.31 -3,085,745 35,640,360
2020-10-02 2020-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 199 257,639 0.08
2020-09-17 2020-09-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -880 257,440 -0.34 148.19 -130,411 38,151,115
2020-09-17 2020-09-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -4,169 258,320 -1.59 147.41 -614,564 38,079,649
2020-09-17 2020-09-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5,977 262,489 -2.23 146.58 -876,139 38,476,950
2020-09-17 2020-09-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5,002 268,466 -1.83 145.53 -727,928 39,069,159
2020-09-17 2020-09-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -2,000 273,468 -0.73 145.27 -290,546 39,727,517
2020-09-04 2020-09-02 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,400 275,468 -1.22 145.25 -493,864 40,012,856
2020-08-31 2020-08-27 4 NVRO NEVRO CORP
Common Stock
S - Sale X -10,819 278,868 -3.73 141.34 -1,529,196 39,416,207
2020-08-31 2020-08-27 4 NVRO NEVRO CORP
Common Stock
S - Sale X -8,081 289,687 -2.71 140.55 -1,135,807 40,716,319
2020-08-17 2020-08-13 4 NVRO NEVRO CORP
Common Stock
S - Sale X -300 347,768 -0.09 140.05 -42,016 48,706,056
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -400 38,054 -1.04 138.70 -55,479 5,277,995
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,000 38,454 -2.53 136.37 -136,373 5,244,087
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,474 39,454 -3.60 135.64 -199,937 5,351,651
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,626 40,928 -3.82 134.42 -218,563 5,501,452
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -2,828 348,068 -0.81 140.11 -396,231 48,767,807
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -2,337 350,896 -0.66 138.87 -324,550 48,730,612
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,813 353,233 -1.07 138.44 -527,868 48,901,223
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -24,208 357,046 -6.35 136.18 -3,296,735 48,623,845
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -19,785 381,254 -4.93 135.58 -2,682,500 51,691,370
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -30,469 401,039 -7.06 134.34 -4,093,257 53,876,261
2020-07-02 2020-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 116 431,508 0.03
2020-05-26 2020-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 1,376 431,392 0.32
2020-04-02 2020-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 274 430,016 0.06
2020-01-03 2019-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 223 429,742 0.05
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -4,610 429,519 -1.06 104.68 -482,572 44,961,791
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -37,116 434,129 -7.88 103.72 -3,849,779 45,029,119
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -8,274 471,245 -1.73 103.07 -852,812 48,571,835
2019-10-02 2019-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 305 479,519 0.06
2019-05-22 2019-05-20 4 NVRO NEVRO CORP
Common Stock
A - Award 2,913 479,214 0.61
2018-05-23 2018-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 3,785 476,301 0.80
2018-05-15 2018-05-11 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -3,631 80,291 -4.33
2018-05-15 2018-05-11 4 NVRO NEVRO CORP
Common Stock
M - Exercise 3,631 472,516 0.77 18.00 65,358 8,505,288
2017-12-22 2017-12-21 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -41,572 0 -100.00
2017-12-22 2017-12-21 4 NVRO NEVRO CORP
Common Stock
M - Exercise 41,572 468,885 9.73 3.60 149,659 1,687,986
2017-10-10 2017-10-05 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5,000 427,313 -1.16 93.50 -467,500 39,953,766
2017-09-28 2017-09-27 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5,000 432,313 -1.14 91.50 -457,500 39,556,640
2017-09-14 2017-09-13 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5,000 42,554 -10.51 89.50 -447,500 3,808,583
2017-09-13 2017-09-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -4,350 47,554 -8.38 88.39 -384,494 4,203,270
2017-09-13 2017-09-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -20,650 51,904 -28.46 87.59 -1,808,705 4,546,199
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3,545 3,545
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 1,518 487,313 0.31
2017-05-03 2017-05-02 4 NVRO NEVRO CORP
Common Stock
S - Sale X -16,000 485,795 -3.19 97.00 -1,552,000 47,122,115
2017-05-03 2017-05-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -13,800 501,795 -2.68 95.00 -1,311,000 47,670,525
2017-04-05 2017-04-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -300 515,595 -0.06 95.17 -28,552 49,070,878
2017-04-05 2017-04-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,900 515,895 -0.37 94.47 -179,493 48,736,497
2017-04-05 2017-04-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -20,000 517,795 -3.72 93.26 -1,865,134 48,287,853
2017-03-30 2017-03-28 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -691 83,922 -0.82
2017-03-30 2017-03-28 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -12,929 41,572 -23.72
2017-03-30 2017-03-28 4 NVRO NEVRO CORP
Common Stock
M - Exercise 691 537,795 0.13 18.00 12,438 9,680,310
2017-03-30 2017-03-28 4 NVRO NEVRO CORP
Common Stock
M - Exercise 12,929 537,104 2.47 3.60 46,544 1,933,574
2017-02-23 2017-02-21 4 NVRO NEVRO CORP
Common Stock
S - Sale X -4,255 0 -100.00 97.30 -414,012
2017-02-23 2017-02-21 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,745 524,175 -0.33 97.30 -169,788 51,002,228
2016-12-02 2016-11-30 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -10,000 54,501 -15.50
2016-12-02 2016-11-30 4 NVRO NEVRO CORP
Common Stock
M - Exercise 10,000 525,920 1.94 3.60 36,000 1,893,312
2016-11-10 2016-11-08 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -30,000 64,501 -31.75
2016-11-10 2016-11-08 4 NVRO NEVRO CORP
Common Stock
M - Exercise 30,000 515,920 6.17 3.60 108,000 1,857,312
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -18,750 81,250 -18.75
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -27,754 84,613 -24.70
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Common Stock
S - Sale X -27,925 485,920 -5.43 96.18 -2,685,947 46,737,875
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Common Stock
S - Sale X -18,579 513,845 -3.49 95.82 -1,780,305 49,238,426
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Common Stock
M - Exercise 18,750 532,424 3.65 63.23 1,185,562 33,665,170
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Common Stock
M - Exercise 27,754 513,674 5.71 18.00 499,572 9,246,132
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -28,918 112,367 -20.47
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -17,587 94,501 -15.69
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Common Stock
S - Sale X -7,906 485,920 -1.60 98.86 -781,608 48,039,315
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Common Stock
S - Sale X -38,599 493,826 -7.25 97.86 -3,777,368 48,326,701
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Common Stock
M - Exercise 28,918 532,425 5.74 18.00 520,524 9,583,650
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Common Stock
M - Exercise 17,587 503,507 3.62 3.60 63,313 1,812,625
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -46,505 112,088 -29.32
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -200 485,920 -0.04 102.29 -20,458 49,704,757
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -700 486,120 -0.14 101.45 -71,015 49,316,534
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5,450 486,820 -1.11 100.11 -545,625 48,737,838
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -7,600 492,270 -1.52 99.00 -752,427 48,736,502
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -20,784 499,870 -3.99 97.98 -2,036,460 48,978,312
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -11,771 520,654 -2.21 97.30 -1,145,371 50,661,977
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
M - Exercise 46,505 532,425 9.57 3.60 167,418 1,916,730
2016-08-24 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,334 4,255 -43.93 99.00 -330,066 421,245
2016-08-24 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,334 4,255 -43.93 99.00 -330,066 421,245
2016-08-24 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,666 485,920 -1.35 99.00 -659,934 48,106,080
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale -3,333 1,165,460 -0.29 89.00 -296,637 103,725,940
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,334 7,589 -30.52 94.00 -313,396 713,366
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,334 7,589 -30.52 94.00 -313,396 713,366
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,333 10,923 -23.38 89.00 -296,637 972,147
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,666 492,586 -1.34 94.00 -626,604 46,303,084
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,667 499,252 -1.32 89.00 -593,363 44,433,428
2016-08-02 2016-07-29 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,333 14,256 -18.95 84.00 -279,972 1,197,504
2016-08-02 2016-07-29 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,333 14,256 -18.95 84.00 -279,972 1,197,504
2016-08-02 2016-07-29 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,667 505,919 -1.30 84.00 -560,028 42,497,196
2016-07-12 2016-07-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,333 17,589 -15.93 79.00 -263,307 1,389,531
2016-07-12 2016-07-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,333 17,589 -15.93 79.00 -263,307 1,389,531
2016-07-12 2016-07-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,667 512,586 -1.28 79.00 -526,693 40,494,294
2016-07-06 2016-07-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,333 20,922 -13.74 74.00 -246,642 1,548,228
2016-07-06 2016-07-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3,333 20,922 -13.74 74.00 -246,642 1,548,228
2016-07-06 2016-07-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,667 519,253 -1.27 74.00 -493,358 38,424,722
2016-05-18 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,666 24,255 -21.56 64.77 -431,783 1,571,091
2016-05-18 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,666 24,255 -21.56 64.77 -431,783 1,571,091
2016-05-18 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -26,667 525,920 -4.83 64.77 -1,727,326 34,065,889
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale -150 2,745,360 -0.01 56.22 -8,433 154,353,199
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -50 30,921 -0.16 58.99 -2,950 1,824,030
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -50 30,921 -0.16 58.99 -2,950 1,824,030
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -407 30,971 -1.30 57.75 -23,503 1,788,461
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -150 31,378 -0.48 56.22 -8,433 1,764,175
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,059 31,528 -16.12 55.01 -333,296 1,734,305
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -408 99,270 -0.41 57.75 -23,560 5,732,465
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,058 99,828 -5.72 55.01 -333,241 5,491,379
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -200 552,587 -0.04 59.06 -11,812 32,637,170
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1,465 552,787 -0.26 57.80 -84,675 31,950,259
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -8,688 554,252 -1.54 56.80 -493,495 31,482,567
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -16,314 562,940 -2.82 55.10 -898,839 31,015,855
2015-12-03 2015-12-01 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 100,000 100,000
2015-11-18 2015-11-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,667 111,199 -5.66 50.52 -336,810 5,617,651
2015-11-18 2015-11-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,667 111,199 -5.66 50.52 -336,810 5,617,651
2015-11-18 2015-11-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -26,667 573,941 -4.44 50.52 -1,347,188 28,994,868
2015-09-03 2015-09-02 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,667 117,866 -5.35 45.30 -302,030 5,339,589
2015-09-03 2015-09-02 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6,667 44,254 -13.09 45.30 -302,029 2,004,799
2015-09-03 2015-09-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -26,667 600,608 -4.25 45.02 -1,200,572 27,039,913
2014-11-07 2014-11-05 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 141,285 141,285
2014-11-07 2014-06-18 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -58,906 158,593 -27.08
2014-11-07 2014-06-18 4 NVRO NEVRO CORP
Common Stock
M - Exercise 58,906 617,404 10.55 3.60 212,062 2,222,654
2014-11-05 3 NVRO NEVRO CORP
Common Stock
1,420,133
2014-11-05 3 NVRO NEVRO CORP
Common Stock
936,057
2014-11-05 3 NVRO NEVRO CORP
Common Stock
854,726
2014-11-05 3 NVRO NEVRO CORP
Common Stock
1,420,133
2014-11-05 3 NVRO NEVRO CORP
Common Stock
936,057
2014-11-05 3 NVRO NEVRO CORP
Common Stock
854,726
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)